approval
saveHADLIMA (ADALIMUMAB-BWWD) — FDA approval
community read0 votes
Sponsor: SAMSUNG BIOEPIS CO LTD. Form: INJECTABLE. Route: INJECTION
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalHADLIMA (ADALIMUMAB-BWWD) — FDA approvalOct 17, 2025 · 352d ago
- approvalHADLIMA (ADALIMUMAB-BWWD) — FDA approvalJun 23, 2025 · 468d ago
- approvalHADLIMA (ADALIMUMAB-BWWD) — FDA approvalMay 21, 2025 · 501d ago
- approvalHADLIMA (ADALIMUMAB-BWWD) — FDA approvalMay 21, 2025 · 501d ago
- approvalHADLIMA (ADALIMUMAB-BWWD) — FDA approvalJul 11, 2023 · 1181d ago
- approvalHADLIMA (ADALIMUMAB-BWWD) — FDA approvalJun 26, 2023 · 1196d ago
- approvalHADLIMA (ADALIMUMAB-BWWD) — FDA approvalApr 26, 2023 · 1257d ago
- approvalHADLIMA (ADALIMUMAB-BWWD) — FDA approvalDec 23, 2022 · 1381d ago
same company · ±60 days · 6
- approvalPYZCHIVA: PYZCHIVA (USTEKINUMAB-TTWE) — FDA approvalJun 28, 2024
- approvalPYZCHIVA: PYZCHIVA (USTEKINUMAB-TTWE) — FDA approvalJun 28, 2024
- approvalEPYSQLI: EPYSQLI (ECULIZUMAB-AAGH) — FDA approvalJul 19, 2024
- approvalOPUVIZ: OPUVIZ (AFLIBERCEPT-YSZY) — FDA approvalMay 20, 2024
- approvalETICOVO: ETICOVO (ETANERCEPT-YKRO) — FDA approvalMay 3, 2024
- approvalETICOVO: ETICOVO (ETANERCEPT-YKRO) — FDA approvalMay 3, 2024
comments(0)
5-min edit window · permanent after that